Additionally, the downstream targets of miR-143 were assessed: the GC cells showed reduced expressions of K-Ras, MMP9, and C-Myc, as well as increased expressions of Bax, caspase-3, and caspase-9 [39]. The gene discussed is CASP9; the disease is gastric cancer.